Correlation Between Terns Pharmaceuticals and EnGene Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and enGene Holdings Common, you can compare the effects of market volatilities on Terns Pharmaceuticals and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and EnGene Holdings.

Diversification Opportunities for Terns Pharmaceuticals and EnGene Holdings

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Terns and EnGene is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and EnGene Holdings go up and down completely randomly.

Pair Corralation between Terns Pharmaceuticals and EnGene Holdings

Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 1.1 times more return on investment than EnGene Holdings. However, Terns Pharmaceuticals is 1.1 times more volatile than enGene Holdings Common. It trades about 0.0 of its potential returns per unit of risk. enGene Holdings Common is currently generating about -0.05 per unit of risk. If you would invest  732.00  in Terns Pharmaceuticals on August 27, 2024 and sell it today you would lose (153.00) from holding Terns Pharmaceuticals or give up 20.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Terns Pharmaceuticals  vs.  enGene Holdings Common

 Performance 
       Timeline  
Terns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
enGene Holdings Common 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in enGene Holdings Common are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, EnGene Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.

Terns Pharmaceuticals and EnGene Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Terns Pharmaceuticals and EnGene Holdings

The main advantage of trading using opposite Terns Pharmaceuticals and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.
The idea behind Terns Pharmaceuticals and enGene Holdings Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Commodity Directory
Find actively traded commodities issued by global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators